The Expanding Role of SGLT2i in CV Disease

1) Welcome to a Tweetorial on #SGLT2i & CV health. “Flozinators of the world, unite!” Accredited for 0.50h by @academiccme: #physicians, #nurses, #pharmacists. I am @mvaduganathan . . . pic.twitter.com/2yfGOqmStm— cardio-met (@cardiomet_CE) May 25, 2021 2)...

GLP-1 RAs, CV Outcomes, Obesity Mgt, & T2D

1) Welcome to a tweetorial on GLP-1 RAs, CV outcomes, obesity mgt, & T2D! Accredited for 0.50h by @academiccme: physicians, nurses, pharmacists! I am @CMichaelGibson . . .— cardio-met (@cardiomet_CE) May 11, 2021 2) Here’s a case. 47M dx’d T2D 4y ago by PCP. On...

The Effects of Dapagliflozin on Worsening Heart Failure

Earn 0.5 CE/CME credits: physicians, nurses, pharmacists! Expert faculty @mkosiborodmd #medtwitter @academiccme #cardiotwitter— cardio-met (@cardiomet_CE) February 25, 2021 2) Accredited for 0.5 credits by @academiccme: physicians, nurses, pharmacists! Expert faculty...

GLP-1 RA Therapy for T2D with CVD

This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter “real time” you can review the course material here and earn the same credit. 2) First, a case study: 65M, new onset...